|
|
|
1-10 employees
View all
|
|
Pharmaceuticals
|
|
Innovation Pharmaceuticals Inc., formerly Cellceutix Corporation, is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies with oncology, dermatology and antimicrobial applications. The Company owns the rights to various drug compounds, including Kevetrin (thioureidobutyronitrile), which is its anti-cancer compound; Prurisol (KM-133), which is in development for psoriasis, and Brilacidin, which is its drug in a class of compounds known as defensin-mimetics. The Company's clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Prurisol for the treatment of psoriasis, and Brilacidin for treatments of skin infections, prevention of oral mucositis complicating chemoradiation treatment for cancer, and ulcerative proctitis. The Company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics and inflammatory disease.
|
Innovation Pharmaceuticals Inc Email Formats | Example Email Formats | Percentage |
---|---|---|
{first} | [email protected] |
100%
|
The widely used Innovation Pharmaceuticals Inc email format is {first} (e.g. [email protected]) with 100% adoption across the company.
To contact Innovation Pharmaceuticals Inc customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.